Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session (Di lunedì 23 maggio 2022)   Study met all primary safety and efficacy endpoints for the Cordella™ PA Pressure Sensor System for the treatment of NYHA class III heart failure patients LISLE, Ill., May 23, 2022 /PRNewswire/

 Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced Positive Data from the SIRONA 2 Clinical Trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System (Cordella Sensor) in New York Heart Association (NYHA) class III heart failure patients. The prospective, multi-center Trial met all primary safety and efficacy endpoints and resulted in low rates of HF hospitalization, further validating pulmonary artery (PA) pressure-guided HF ...Leggi su iltempo